Lithium Triangle a "Treasure Trove" for the Popular Energy Metal
Lithium is the most precious commodity of the green revolution, and experts predict an exploding demand for the energy metal. Surrounded by multi-billion dollar assets, one little-known small-cap company in a renowned location in South America may become a strong link in the lithium supply chain due to a monster acquisition.
Put this company on your radar now.
William R. Carapezzi, Jr., insider at Pfizer

William R. Carapezzi, Jr. Insider Information

EVP of Pfizer
Bill Carapezzi is Executive Vice President, Global Business Services and Transformation, responsible for global procurement, global financial shared services, human resources operations, real estate, and the financial project management office, as well as for elements of commercial operations.

Previously, Bill was Senior Vice President of Global Business Operations. In this role, Bill led global financial solutions, procurement, workplace solutions, tax, insurance and the financial portfolio management office. Bill joined Pfizer in March 2008 as the Senior Vice President of Global Tax.

Prior to joining Pfizer, Bill was with Lucent Technologies, Inc., for 18 years in a variety of roles including Executive Vice President & General Counsel and Vice President of Treasury & Tax. In addition, Bill spent six years in public accounting at Arthur Andersen & Co.

Bill holds a Bachelor of Science degree in Accounting from Fairfield University, a Juris Doctor (JD) from Western New England School of Law, and a LL.M in Taxation from New York University School of Law. He is also a Certified Public Accountant.

What is William R. Carapezzi, Jr.'s net worth?

The estimated net worth of William R. Carapezzi, Jr. is at least $1.93 million as of May 12th, 2022. Mr. Carapezzi, Jr. owns 38,146 shares of Pfizer stock worth more than $1,932,476 as of June 29th. This net worth approximation does not reflect any other assets that Mr. Carapezzi, Jr. may own. Learn More about William R. Carapezzi, Jr.'s net worth.

How do I contact William R. Carapezzi, Jr.?

The corporate mailing address for Mr. Carapezzi, Jr. and other Pfizer executives is 235 EAST 42ND STREET, NEW YORK NY, 10017. Pfizer can also be reached via phone at (212) 733-2323. Learn More on William R. Carapezzi, Jr.'s contact information.

Has William R. Carapezzi, Jr. been buying or selling shares of Pfizer?

During the last quarter, William R. Carapezzi, Jr. has sold $1,645,400.00 in Pfizer stock. As far as recent transactions, 0 shares of BMO Capital Markets stock in a transaction that occurred on Wednesday, June 29th. Learn More on William R. Carapezzi, Jr.'s trading history.

Who are Pfizer's active insiders?

Pfizer's insider roster includes Ronald Blaylock (Director), Loretta Cangialosi (VP), William Carapezzi, Jr. (EVP), Frank D'Amelio (EVP), Jennifer Damico (SVP), Jennifer Damico (SVP), Rady Johnson (Insider), Douglas Lankler (EVP), Alexander Mackenzie (EVP), Laurie Olson (Insider), Ian Read (CEO), Dawn Rogers (EVP), Sally Susman (Insider), and John Young (Insider). Learn More on Pfizer's active insiders.

Are insiders buying or selling shares of Pfizer?

In the last year, insiders at the biopharmaceutical company sold shares 8 times. They sold a total of 276,647 shares worth more than $14,190,373.18. The most recent insider tranaction occured on June, 7th when SVP Jennifer B Damico sold 4,218 shares worth more than $227,603.28. Insiders at Pfizer own 0.1 % of the company. Learn More about insider trades at Pfizer.

Information on this page was last updated on 6/7/2022.

William R. Carapezzi, Jr. Insider Trading History at Pfizer

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/12/2022Sell32,908$50.00$1,645,400.0038,146View SEC Filing Icon  
See Full Table

William R. Carapezzi, Jr. Buying and Selling Activity at Pfizer

This chart shows William R Carapezzi Jr's buying and selling at Pfizer by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Pfizer Company Overview

Pfizer logo
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Read More

Today's Range

Now: $50.66
Low: $50.41
High: $51.97

50 Day Range

MA: $50.49
Low: $46.53
High: $53.99

2 Week Range

Now: $50.66
Low: $38.82
High: $61.71


15,581,883 shs

Average Volume

29,501,258 shs

Market Capitalization

$284.25 billion

P/E Ratio


Dividend Yield



Tailor an Options Trading Strategy to Fit Your Needs
This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.
Download your FREE Options Strategy Guide Today.